We Work for Health | Delaware

08/07/2026

Join AIDS Delaware and Delaware HIV Consortium on Saturday, September 19, 2026 for our 40th AIDS Walk Delaware celebration. www.aidswalkdelaware.org

As one of the nation's longest-running HIV/AIDS walks, AIDS Walk Delaware has brought communities together for four decades to honor lives, fight stigma, support people living with HIV, and advance the work of prevention, care, and advocacy.

📍 Brandywine Park, Wilmington
📍 The Bandstand, Rehoboth Beach

⏰ Check-in starts at 8:30 a.m., and the walk begins at 10.
This year, we celebrate 40 years of community, compassion, resilience, and action.

08/06/2026

Save the date! 🏁 The Monster Mile Walk for a Cause returns to Dover Motor Speedway on Sunday, October 11. PLUS, Delaware Breast Cancer Coalition is adding a brand-new 5K alongside our traditional 1-mile walk!

Bring your friends, lace up, and join us as we move together for breast cancer support and hope.🩷

Learn more or register at https://runsignup.com/Race/DE/Dover/MonsterMileWalkForACause5K

07/30/2026

You’re invited to “Rooted in Resilience,” a special morning just for cancer survivors, hosted by the Sussex County Survivorship Coalition. 💚

Join us on Thursday, September 10, from 9 am to 12 pm at the beautiful Delaware Botanic Gardens for light breakfast, a soothing sound healing session, an inspiring keynote presentation, and more meaningful ways to relax, connect, and feel supported.

Register today! https://form.jotform.com/212424866341151

07/20/2026

The Delaware Division of Substance Abuse and Mental Health is offering important free online trainings that are open to the public. Classes like these are how we grow the community of recovery.

To register for Introduction to Mental Health First Aid or Removing the Stigma of Substance Use Disorder/Addiction:
https://www.eventbrite.com/o/dsamh-behavioral-health-support-team-102625014431

To register for the full-day Mental Health First Aid certification class, email:
[email protected]

07/07/2026

Are we solving the wrong problem when it comes to U.S. prescription drug pricing?

A fascinating new paper by Kristian Stout, "Don't Import the Distortion: Why Drug Pricing Would Weaken U.S. Innovation," challenges one of the most common assumptions in healthcare policy—that because Americans pay more for prescription drugs than patients in other countries, we should simply adopt those countries' pricing models.

The paper argues that the issue isn't simply that U.S. drug prices are too high. Rather, many foreign governments suppress the price of innovative medicines through government purchasing power, price controls, health technology assessments, and external reference pricing—effectively shifting much of the world's pharmaceutical R&D costs onto the United States.

One statement stood out:

"The United States should confront foreign price suppression, not copy it."

That's a powerful distinction.

According to the report, implementing Most-Favored-Nation (MFN) pricing in the U.S. would not eliminate market distortions—it would import them.
The paper warns that the likely consequences include:

• Fewer breakthrough medicines reaching patients

• Reduced investment in high-risk research such as oncology, neurology, and rare diseases

• Greater pressure to move pharmaceutical manufacturing offshore

• Weaker long-term U.S. leadership in medical Council for Innovation Promotion

Another striking quote:
"Compressing the U.S. revenue base does not redistribute global pharmaceutical investment. It shrinks it."

The report cites research estimating that a 20% reduction in expected U.S. pharmaceutical revenue could result in approximately 8.6% fewer new drugs developed by U.S. companies. Those losses would likely be concentrated in the very therapies that patients with the greatest unmet medical needs are waiting for.

Perhaps the most important takeaway is that this debate shouldn't simply be framed as "high prices versus low prices."

As the paper explains:

"The U.S.–foreign price gap is therefore not simply a pricing problem. It is a trade problem."

Rather than adopting foreign government pricing models, the author argues that policymakers should address what he describes as unfair international pricing practices through trade policy—encouraging other nations to contribute a more proportionate share toward the global cost of pharmaceutical innovation.

Whether you agree with every recommendation or not, the paper raises an important question:
How do we lower costs for patients today without undermining the innovation that delivers tomorrow's cures?

That's a conversation worth having—especially as policymakers continue debating drug pricing reforms.

Read the full article: https://laweconcenter.org/resources/dont-import-the-distortion-why-mfn-drug-pricing-would-weaken-u-s-innovation/

06/16/2026

Celebrate America's 250th birthday on the Wilmington Riverfront!

Join us for an afternoon and evening filled with live entertainment, family activities, local food and drinks, Delaware-made vendors, exhibits, and much more as we commemorate this historic milestone together.

The celebration concludes with a spectacular fireworks display over the Christina River, accompanied by music from the Delaware Symphony Orchestra. Bring your family and friends to help us celebrate 250 years of American history right here in Wilmington.

- Riverfront Wilmington�
- July 4, 2026�
- FREE admission
- ‎Begins at 2 pm and concludes with fireworks show

06/16/2026

Great to hear this news! Congresswoman Sarah McBride running again!

Representative Sarah McBride launches reelection bid after 57-stop Delaware tour. For more information click on the story link in the comments below.

06/16/2026

We're facing an urgent situation: Patient care could be impacted in the weeks ahead due to a steep drop in scheduled blood donations.

We need blood donors to help patients who are counting on lifesaving blood following accidents, during surgeries, and for treatment of conditions such as sickle cell disease and cancer.

You can help by scheduling an appointment to give blood or platelets: https://rdcrss.org/4vQbfgQ

06/16/2026

06/16/2026

Important legislation in Delaware.

Thirteen years ago, atTAcK addiction championed the 911/Good Samaritan Law with the General Assembly and Governor Jack Markell. We knew that lives could not be changed, unless they, first, could be saved. atTAcK addiction's Liz and Marty Perkins and Dave Humes gave heartbreaking firsthand accounts that the prospect of individuals being arrested for low-level drug crimes because they were using in the same place as someone who had overdosed prevented them from calling 911 for help.

From those early days of advocacy came a simple mantra: First, save the life.

And it is the same, today, with Senate Bill 249. Individuals are reluctant to seek treatment or even to confide in someone that they are using if they are carrying paraphernalia and risk the possibility of arrest. We can't hope to convince people to go to treatment if they're more worried about going to jail.

Senate Bill 249, which creates a clear, regulated framework for harm reduction programs and prevents individuals from being arrested, charged and prosecuted simply for possessing items that reduce the risk of overdose and disease transmission, has already passed the Senate. atTAcK addiction urges the House Health & Human Development Committee and the full House to approve this legislation - and help us save the next life.